/PYVAX
PYVAX Stock - Payden Equity Income Fund Adviser Cl
Financial Services|Asset Management - IncomeNASDAQ
$17.78+0.45%
+$0.08 (+0.45%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.61
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.86
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $19.56
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PYVAX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$17.60 – $17.96
TARGET (TP)$20.45
STOP LOSS$16.36
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.84
52W High$17.91
52W Low$14.32
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $9.20M | $10.49M | $10.52M | $11.58M | $10.44M |
| Gross Profit | $9.20M | $10.49M | $10.52M | $11.58M | $10.44M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $2.19M | $2.86M | $2.92M | $5.00M | $3.99M |
| Net Income | $111.63M | $-101,492,752 | $142.37M | $66.71M | $9.72M |
| Net Margin | 1213.7% | -967.4% | 1353.2% | 576.3% | 93.1% |
| EPS | $2.77 | $-2.53 | $3.62 | $1.70 | $0.25 |
Company Overview
The investment seeks growth of capital and some current income. The fund invests primarily in large capitalization value stocks, defined as stocks with above average dividend yields and large market capitalizations, and other income producing equity securities, including by way of example, preferred stocks, real estate investment trusts and master limited partnerships. It invests principally in U.S. securities, but may invest up to 30% of its total assets in foreign securities, including companies organized or headquartered in emerging markets.
Loading analyst ratings...
Earnings History & Surprises
PYVAXLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about PYVAX
What is PYVAX's current stock price?
Payden Equity Income Fund Adviser Cl (PYVAX) is currently trading at $17.78 per share. The stock has moved +0.45% today.
What is the analyst price target for PYVAX?
No analyst price targets are currently available for this stock.
What sector is Payden Equity Income Fund Adviser Cl in?
Payden Equity Income Fund Adviser Cl operates in the Financial Services sector, specifically within the Asset Management - Income industry. The company is traded on the NASDAQ exchange.
What is PYVAX's market cap?
Payden Equity Income Fund Adviser Cl has a market capitalization of $1.26 billion, making it a small-cap company.
Does PYVAX pay dividends?
No, Payden Equity Income Fund Adviser Cl does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorABCVX
American Beacon The London Company Income Equity Fund Investor Class
$23.33
Mkt Cap: $1.1B
BMDIX
Baird Mid Cap Growth Fund - Institutional Class
$19.32
Mkt Cap: $1.1B
BMDSX
Baird Mid Cap Growth Fund - Investor Class
$17.16
Mkt Cap: $1.1B
EOS
Eaton Vance Enhanced Equity Income Fund II
$22.62
Mkt Cap: $1.2B
FPF
First Trust Intermediate Duration Preferred & Income Fund
$18.59
Mkt Cap: $1.1B
PACIX
Columbia Fds Srs Tr, Columbia Convertible Securities Fund Class A
$25.80
Mkt Cap: $1.2B
PYVSX
Payden Equity Income Fund SI Class
$17.88
Mkt Cap: $1.3B
RYTFX
Royce Total Return Fund Service Class
$7.29
Mkt Cap: $1.2B
SSIRX
Sierra Tactical Core Income Fund Institutional Class
$19.74
Mkt Cap: $1.2B
SSIZX
Sierra Tactical Core Income Fund Class A
$19.84
Mkt Cap: $1.2B
Explore stocks similar to PYVAX for comparison